FDA approves Retatrutide this year?
Smart Money Analysis
21 top-performing wallets have taken positions on this market, with a 71% consensus betting NO. This creates a significant 21.5% edge between the smart money consensus and the current market price of $0.77. Total tracked exposure from smart wallets stands at $56.2K.
Opportunity Metrics
Score: 12Alpha Signal: BUY_NO
21 smart wallets • STRONG_NO consensus (71%)
Market Stats
Key Questions
What are the current Polymarket odds on "FDA approves Retatrutide this year?"?â–¾
As of the latest data, YES is trading at $0.23 (23.5% implied probability) and NO is trading at $0.77 (76.5% implied probability). The market has $0K in 24-hour trading volume.
What is smart money betting on "FDA approves Retatrutide this year?"?â–¾
21 tracked smart wallets are positioned on this market with a 71% consensus betting NO. These wallets have a combined exposure of $56.2K. The alpha score is 14 out of 100.
What is the alpha score for this market?â–¾
This market has an alpha score of 14 out of 100, which indicates moderate tracking interest. The alpha score measures the concentration and conviction of high-performing wallets positioned in this market.
How can I trade this market?â–¾
You can trade this market directly through Polymarket, or use PolyFire's Telegram bot for instant execution with copy trading, AI signals, and smart wallet tracking. PolyFire charges a 1% fee on trades only and is fully non-custodial.
What does the consensus edge mean?â–¾
The 21.5% consensus edge represents the gap between what smart money is paying and where the market currently trades. A larger edge suggests smart wallets see value that the broader market hasn't priced in yet.